DeepSeek Restarts $8B Funding Round at ~$74B Valuation

DeepSeek has quietly turned the taps back on. According to Bloomberg, the Hangzhou-based lab has resumed a second funding round that it paused last month, is now aiming to raise close to $8 billion, and is doing so at a pre-money valuation near 500 billion yuan, roughly $74 billion. Monolith Management is in talks to join a syndicate that already lines up China's national AI fund, NetEase, JD.com, IDG Capital, Loyal Valley Capital and Shixiang Capital.

The pause itself is part of the story. Bloomberg's reporting attributes the earlier hold to founder Liang Wenfeng's frustration over online reports of remarks he made to investors during the first round, and the company and its backers are reportedly hoping to close this restart quietly, with agreements expected to be signed in late August. That framing matters, because DeepSeek is preparing for an onshore IPO, and a founder who dislikes leaks running a very public capital raise is a governance signal worth watching.

The valuation is the number that should stop people. A jump from the roughly 450 billion yuan post-money mark of the earlier round to a 500 billion yuan pre-money for this one is not a small step, and it is being set by a mix of Chinese state-linked capital, big platform strategics, and offshore-linked investors like Monolith. That combination is how a national champion gets priced, not how a normal venture round gets priced, and it puts DeepSeek in a bracket usually reserved for the biggest US AI labs.

The honest caveat is that almost everything specific here, including Monolith's participation, the $8 billion target, and the late-August timing, is single-sourced to Bloomberg and framed as reporting rather than disclosure. What the coverage does not give you is the split between primary and secondary capital, the intended IPO venue and timeline, or how DeepSeek plans to spend the money against a compute market still shaped by US export controls.

The forward-looking read is straightforward. If this round closes on the reported terms, the argument that Chinese frontier AI is capital-starved gets harder to make, and the strategic buyers around the table, NetEase, JD.com, and the national AI fund in particular, quietly lock in preferred access to a lab that just proved it can price like the Americans.